These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19118113)

  • 1. Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.
    Garrison AP; Dekaney CM; von Allmen DC; Lund PK; Henning SJ; Helmrath MA
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G643-50. PubMed ID: 19118113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.
    Dubé PE; Rowland KJ; Brubaker PL
    Endocrinology; 2008 Jan; 149(1):291-301. PubMed ID: 17884945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice.
    Dekaney CM; Fong JJ; Rigby RJ; Lund PK; Henning SJ; Helmrath MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1013-22. PubMed ID: 17855764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
    Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
    Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.
    Nelson DW; Murali SG; Liu X; Koopmann MC; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1175-84. PubMed ID: 18256135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.
    Koopmann MC; Nelson DW; Murali SG; Liu X; Brownfield MS; Holst JJ; Ney DM
    JPEN J Parenter Enteral Nutr; 2008; 32(3):254-65. PubMed ID: 18443137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-Like Peptide-2 Stimulates S-Phase Entry of Intestinal Lgr5+ Stem Cells.
    Chen ME; Naeini SM; Srikrishnaraj A; Drucker DJ; Fesler Z; Brubaker PL
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1829-1842. PubMed ID: 35218981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.
    Murali SG; Brinkman AS; Solverson P; Pun W; Pintar JE; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G794-804. PubMed ID: 22281475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartame supplementation in starter accelerates small intestinal epithelial cell cycle and stimulates secretion of glucagon-like peptide-2 in pre-weaned lambs.
    Sun D; Liu L; Mao S; Zhu W; Liu J
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1338-1350. PubMed ID: 31342562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
    Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
    J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF binding protein-4 is required for the growth effects of glucagon-like peptide-2 in murine intestine.
    Austin K; Imam NA; Pintar JE; Brubaker PL
    Endocrinology; 2015 Feb; 156(2):429-36. PubMed ID: 25514089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
    Yusta B; Holland D; Waschek JA; Drucker DJ
    Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for the intestinal epithelial insulin-like growth factor-1 receptor in the intestinal responses to glucagon-like peptide-2 and dietary fat.
    Markovic MA; Srikrishnaraj A; Tsang D; Brubaker PL
    FASEB J; 2020 May; 34(5):6628-6640. PubMed ID: 32212202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding colostrum or a 1:1 colostrum:milk mixture for 3 days postnatal increases small intestinal development and minimally influences plasma glucagon-like peptide-2 and serum insulin-like growth factor-1 concentrations in Holstein bull calves.
    Pyo J; Hare K; Pletts S; Inabu Y; Haines D; Sugino T; Guan LL; Steele M
    J Dairy Sci; 2020 May; 103(5):4236-4251. PubMed ID: 32171512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts.
    Leen JL; Izzo A; Upadhyay C; Rowland KJ; Dubé PE; Gu S; Heximer SP; Rhodes CJ; Storm DR; Lund PK; Brubaker PL
    Endocrinology; 2011 Feb; 152(2):436-46. PubMed ID: 21159855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic GLP-2 levels do not limit adaptation after distal intestinal resection.
    Topstad D; Martin G; Sigalet D
    J Pediatr Surg; 2001 May; 36(5):750-4. PubMed ID: 11329581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function.
    Dong CX; Zhao W; Solomon C; Rowland KJ; Ackerley C; Robine S; Holzenberger M; Gonska T; Brubaker PL
    Endocrinology; 2014 Feb; 155(2):370-9. PubMed ID: 24265452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.